RadNet, Inc. (RDNT): Shareholders' Equity
$1.36B
As of 2025-12-31
$1.39B
As of 2026-06-30
+40.3%
3-year compound annual growth
+39.3%
5-year compound annual growth
+43.6%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.36B | +19.6% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $1.13B | +39.3% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $813.36M | +65.5% | 2026-03-02, Balance as of period end |
| 2022-12-31 | $491.45M | +42.0% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $346.16M | +34.0% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $258.30M | +10.8% | 2023-03-01, Balance as of period end |
| 2019-12-31 | $233.14M | +16.4% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $200.25M | +186.4% | 2021-03-16, Balance as of period end |
| 2017-12-31 | $69.92M | +34.3% | 2020-03-16, Balance as of period end |
| 2016-12-31 | $52.05M | +42.8% | 2019-03-18, Balance as of period end |
| 2015-12-31 | $36.46M | +373.6% | 2017-03-17, Balance as of period end |
| 2014-12-31 | $7.70M | +248.3% | 2017-03-17, Balance as of period end |
| 2013-12-31 | $2.21M | n/m | 2016-03-15, Balance as of period end |
| 2012-12-31 | -$6.68M | n/c | 2015-03-16, Balance as of period end |
| 2011-12-31 | -$70.76M | n/c | 2013-03-18, Balance as of period end |
| 2010-12-31 | -$82.47M | n/m | 2012-03-13, Balance as of period end |
| 2009-12-31 | -$74.76M | n/a | 2012-03-13, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 2025-12-31 | $1.36B | +19.6% |
| Natera, Inc. (NTRA) | 2025-12-31 | $1.71B | +43.2% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $563.50M | -58.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$99.31M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $577.31M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.31B | +11.4% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $303.10M | -19.9% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $7.21B | +5.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $470.87M | +3.3% |
Compare RDNT, NTRA, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗